Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 8/20 | 0.56 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.49 |
| ▸ | AKT1 | P31749 | 1/20 | 0.45 |
| ▸ | AKT2 | P31751 | 1/20 | 0.45 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035340 | 0.95 | PIK3CA (0.57) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035605 | 0.93 | PIK3CA (0.60) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31034946 | 0.93 | PIK3CA (0.60) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035069 | 0.90 | PIK3CA (0.58) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035391 | 0.89 | AKT1 (0.48) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035108 | 0.88 | PIK3CA (0.52) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035819 | 0.88 | PIK3CA (0.58) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035404 | 0.87 | PIK3CA (0.51) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035202 | 0.86 | PIK3CA (0.45) | PIK3CAPIK3CBAKT1AKT2AKT3 | |
| SCHEMBL31035672 | 0.86 | PIK3CA (0.62) | PIK3CAAKT1AKT2AKT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |